Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fracture Prevention Trial: Teriparatide in Postmenopausal Osteoporosis
NCT00670501Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 1996
- Primary completion
- Apr 1999
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of teriparatide in postmenopausal osteoporosis, sponsored by Eli Lilly and Company. Started Aug 1996; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00670501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00670501.